Is blood testing for Lyme disease accurate?

Limitations of Blood Testing

Blood tests for Lyme disease detect antibodies produced by the body in response to the bacteria, Borrelia burgdorferi. However, these tests can return false negatives in the early stages of infection, when the body has not yet produced antibodies, or in people with weakened immune systems. According to the Centers for Disease Control and Prevention (CDC), blood tests may miss up to 60% of early-stage cases.

Interpreting Blood Test Results

To accurately diagnose Lyme disease, healthcare providers must consider the patient’s symptoms, medical history, and exposure to ticks. Blood tests are often used in conjunction with physical examinations and other diagnostic methods, such as clinical assessment and imaging studies. When interpreting blood test results, healthcare providers look for a combination of specific antibodies, including IgM and IgG, to confirm a Lyme disease diagnosis. A positive test result typically indicates the presence of both IgM and IgG antibodies, although the presence of IgG alone may also indicate past or current infection.

Alternative Diagnostic Methods

In cases where blood tests are inconclusive, healthcare providers may use alternative diagnostic methods, such as polymerase chain reaction (PCR) testing, which detects the genetic material of the bacteria. Another method is to perform a skin biopsy, where a small sample of tissue is taken from the affected area. While these methods can provide more accurate results, they are typically more expensive and invasive than blood tests.